GLP-1s in Addiction Medicine: An Update Since Our Last Conversation

Episode 37

0:00-33:32

In this episode of ASAM Practice Pearls, Dr. Stephen Taylor welcomes back Dr. Stephanie Weiss and is joined by Dr. Anna Lembke to explore an update on GLP-1 receptor agonists for alcohol use disorder (AUD), discussing current research, how things have evolved since the last discussion, and the challenges and implications of integrating these innovative treatments into addiction care. ----more---- Looking for this episode's transcript? Download it HERE Get credit for listening! Claim your 0.5 CEs HERE Have an idea for a future episode? Share it with us at education@asam.org. Host Stephen M. Taylor, MD, MPH, DFAPA, DFASAM Dr. Stephen M. Taylor is ASAM's President and is board certified in general psychiatry, child and adolescent psychiatry, addiction psychiatry, and addiction medicine. With over 30 years of practice experience, Dr. Taylor is dedicated to helping adolescents and adults overcome addiction and co-occurring psychiatric disorders. He has served as the Medical Director of the NBA and NBPA Player Assistance and Anti-Drug Program for 16 years and is the Chief Medical Officer of Pathway Healthcare, which operates multiple outpatient addiction and mental health treatment offices across six states. Expert Stephanie Weiss, MD, PhD Dr. Stephanie Weiss is a Research Physician with the Translational Addiction Medicine Branch (TAMB) of the NIDA Intramural Research Program.

Publisher

ASAM Practice Pearls

Link

asampracticepearls.podbean.com/e/glp-1s-in-addiction-medicine-an-update-since-our-last-conversation/

Published

August 24, 2026

Duration

34 min

Format

Podcast

Category

Lifestyle · Medicine

Source

RSS feed

Host

ASAM Education

AP

ASAM Practice Pearls

@asampracticepearls

#addictionmedicine #conversation #medicine

The Nile